drugset
drugset / Trial / NCT01535443

Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers.

NCT01535443 ↗

Phase 1 Completed 35 enrolled Laboratorios Sophia S.A de C.V.
NaSingle-groupOpen-labelTreatment

Summary

Study to evaluate the safety and tolerability of PRO-155 Ophthalmic Solution 0.09 % in healthy volunteers.

Timeline

Start
2011-09
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromfenac Other / unclassified 0.09 % Other

Indications

cataract